Beta Bionics Inc (NASDAQ:BBNX) shares, rose in value on Wednesday, June 18, with the stock price down by -2.47% to the previous day’s close as strong demand from buyers drove the stock to $17.78.
Actively observing the price movement in the last trading, the stock closed the session at $18.23, falling within a range of $17.77 and $19.08. Referring to stock’s 52-week performance, its high was $24.50, and the low was $8.89. On the whole, BBNX has fluctuated by 17.75% over the past month.
With the market capitalization of Beta Bionics Inc currently standing at about $770.94 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-May-07.
The stock’s technical analysis shows that the price of BBNX currently trading nearly 0.44% and 24.43% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 54.42, while the 7-day volatility ratio is showing 3.41% which for the 30-day chart, stands at 4.93%. Furthermore, Beta Bionics Inc (BBNX)’s average true range (ATR) is 1.42.
Data on historical trading for Beta Bionics Inc (NASDAQ:BBNX) indicates that the trading volumes over the past 10 days have averaged 0.44 and over the past 3 months, they’ve averaged 557.53K. According to company’s latest data on outstanding shares, there are 43.35 million shares outstanding.
Nearly 23.36% of Beta Bionics Inc’s shares belong to company insiders and institutional investors own 83.50% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 4.13 million shares as on 2025-05-30, resulting in a short ratio of 8.18. According to the data, the short interest in Beta Bionics Inc (BBNX) stood at 1077.00 of shares outstanding as of 2025-05-30; the number of short shares registered in 2025-04-30 reached 3.54 million. The stock has fallen by -24.76% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the BBNX stock heading into the next quarter.
